Where all your ID needs are met! Sort of.
The hits keep coming and they don’t stop coming. I’ve had a bit of a lull lately, but am back to bring short, and hopefully, sweet post. Daptomycin has become a go-to antibiotic for MRSA infections, namely bacteremia, as organisms with resistance to vancomycin have risen in the past few years. The 2006 Fowler study
Look, I know I have talked a lot about staphylococcus but there is a ton of details that go into the therapeutic aspects of it. When it comes to staphylococcus aureus bacteremia, specifically MRSA, vancomycin is the first line therapy per the IDSA guidelines (1). I have discussed the issues with vancomycin dosing, and how
I’ve previously discussed how much more difficult Enterococcal infections are to treat when compared to other bacteria such as streptococci. This stems from the fact these bacteria have tend to be more resistant to beta-lactam antibiotics, with synergy being the name of the game for serious infections with these bacteria (in general, ampicillin/ceftriaxone). This is
So MRSA is really hard to kill. If you have done any sort of ID, you will not be surprised by that statement. MRSA bacteremia has a high relapse rate. Because of this, people have tried multiple types of antibiotics, including Daptomycin and Ceftaroline, have been used with minimal change in the outcomes. In the
Dr. Germophile 